Vascular Solutions
Advanced cardiovascular ultrasound systems for cardiac imaging
Company profile
Company profile
GE HealthCare is a leading global medical technology and digital solutions company that develops and manufactures intelligent devices, advanced imaging systems, and AI-powered software to enable precision health. The company's comprehensive portfolio spans medical imaging (CT, MRI, X-ray, ultrasound, mammography, molecular imaging), patient care solutions (monitoring, anesthesia, maternal-infant care), pharmaceutical diagnostics (contrast media and molecular imaging agents), and enterprise software platforms. GE HealthCare's AI and digital solutions include advanced visualization tools, PACS and AI orchestration platforms, enterprise imaging systems, hospital operations command centers, and integrated care applications. The company leverages artificial intelligence across its product lines to improve diagnostic accuracy, workflow efficiency, and clinical outcomes. With a focus on precision care, GE HealthCare serves hospitals, health systems, imaging centers, research institutions, pharmaceutical companies, and government healthcare organizations globally. The company provides end-to-end solutions from medical devices and imaging agents to cybersecurity, predictive maintenance services, clinical education, and healthcare financial services. GE HealthCare operates internationally with localized support across North America, Europe, Asia-Pacific, Latin America, and the Middle East.
Company description GE HealthCare official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Api Only · Cloud Saas · Embedded · Hybrid · On Premise deployment with recorded integration context.
Recorded integration context: Cardiology IT systems (Centricity), Cerner, Enterprise PACS systems, Epic, Hospital information systems, VNA (Datalogue).
Company milestones
Spun off from General Electric as independent public company in January 2023, launched multiple AI-powered imaging solutions, expanded Command Center hospital operations platform, introduced CareIntellect integrated care applications
Partnerships
No partners are currently listed.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Advanced cardiovascular ultrasound systems for cardiac imaging
Comprehensive cardiology IT and information management platform
Automated breast ultrasound system
Automated breast ultrasound screening system
Advanced visualization and post-processing platform for medical imaging
Integrated care applications for clinical decision support
Cardiology IT and imaging informatics platform
AI-powered hospital operations management platform
AI-powered hospital operations management and optimization platform
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
European journal of radiology open · Dec 1, 2026
Health-economic impact of implementing continuous vital sign monitoring in post-surgical patients in five European countries.Journal of medical economics · Dec 1, 2026
Integrated radiopathomics nomogram for predicting angiogenic microvascular patterns in NSCLC: a dual-center validation study.Annals of medicine · Dec 1, 2026
Impact of obesity and type 2 diabetes on muscle power, quality, and force-velocity, and their relation to functional capacity.Journal of diabetes and metabolic disorders · Dec 1, 2026
Neuroclearance dysfunction in autism with sleep disorder: MRI evidence and mediation by systemic iron deficiency.Journal of affective disorders · Oct 15, 2026
Development and performance evaluation of an upright dedicated cone-beam breast CT system.Medical physics · Sep 1, 2026
Clinical validation
NCT07609225 · Sponsor · NOT YET RECRUITING
Ultrasound of the Spleen Utilizing Low-energy (Diagnostic Level) Insonification.NCT06934096 · Sponsor · RECRUITING
Automated Non-Invasive Blood Pressure StudyNCT07790458 · Sponsor · RECRUITING
Data Collection of New Spectral CT Imaging MethodNCT07661706 · Sponsor · RECRUITING
Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate CancerNCT06024772 · Sponsor · NOT YET RECRUITING
MCE Molecular Imaging for MyocarditisNCT07538544 · Sponsor · NOT YET RECRUITING
Regulatory
K253686 · 510k · Mar 23, 2026
Senographe Pristina 3DP130020/S005 · Pma · Nov 21, 2025
MR Contour DLK242925 · 510k · Apr 1, 2025
True Enhance DLK233698 · 510k · Apr 11, 2024
SIGNA ChampionK233728 · 510k · Jan 19, 2024
Precision DLK223212 · 510k · Apr 27, 2023
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on GE HealthCare's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.